Ignite Creation Date:
2024-05-06 @ 6:28 PM
Last Modification Date:
2024-10-26 @ 2:48 PM
Study NCT ID:
NCT05675462
Status:
RECRUITING
Last Update Posted:
2023-03-06
First Post:
2022-12-29
Brief Title:
Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib as Second-line or Later Therapy in Patients With Advanced Hepatocellular Carcinoma
Sponsor:
Fudan University
Organization:
Fudan University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-12-29
First Submit QC Date:
December 29 2022
Study First Post Date:
2023-01-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-02
Last Update Post Date:
2023-03-06
Last Update Post Date Type:
ACTUAL